Navigation Links
Spending on Diabetes Drugs Soars in US

One more indicator of the growing epidemic of diabetes in the US is out. Spending on diabetes drugs is spiraling by leaps and bounds .

According to a drug trend report released by the Medico Health Solutions, diabetes treatments trailed only cholesterol medications in total prescription drug spending growth in 2006.

An aging population and the alarming rise in obesity a leading cause of diabetes are expected to push spending growth rates on diabetes drugs up 16 percent to 20 percent annually.

The analysis projects that, by 2009, spending on medicines to treat diabetes could soar by 60 percent to 68 percent from 2006 levels. Spending on diabetes treatments increased 14.5 percent from 2005 to 2006 and the use of diabetes drugs increased 5.1 percent. The U.S. sales of diabetes drugs reached $9.88 billion in 2005.

Use is expected to increase by 8 percent to 10 percent each year, with patients more frequently using new drug combinations to reach target blood sugar levels, the Medco analysis of likely future prescription drug spending and utilization found.

There are going to be a lot more drugs coming out and more and more people with type 2 diabetes will catapult diabetes to the number one class in driving year over year spending growth, Dr. Lon Castle, director of medical policy for Medco, said in an interview.

A wave of new diabetes treatments, such as Merck & Co.s, Januvia, and Byetta from Eli Lilly and Co. and Amylin Pharmaceuticals Inc.; and others expected to hit the market from the likes of Novartis AG and Novo Nordisk A/S will help push up treatment costs, the report said.

Some newer drugs that act on new targets are increasingly being prescribed as first-line therapy and are frequently being used in combination with other drugs, driving up costs this year and going forward, the report said.

Use of lower cost generic drugs could mitigate pricing pressures, said Medco, a pharmacy benefits manager that negotiates prescription drug costs for companies and other large clients.

But while new medicines and combination therapies can be expensive, the cost of treating complications from untreated diabetes would create a much larger burden on government and private health plans and patient pocketbooks.

Diabetes and, in particular, type 2 diabetes, is becoming much more prevalent among people of all ages, Medco Chief Medical Officer Robert Epstein said in a statement.

While prevention of type 2 diabetes needs to be a national priority, drug treatments can help prevent the onset of complications from diabetes that lead to hospitalizations, more complex treatment and dramatically higher costs, Epstein said.


'"/>




Related medicine news :

1. More Spending Does Not Ensure Better Healthcare
2. Western Australian Government Spending Extra For Mental Health Services
3. Lowest Spending growth in US Medicaid
4. Variation in U.S. Healthcare Spending
5. States Spending may Help Keep Childless Seniors Independent
6. Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending
7. G8 Members To Announce Plans To Increase HIV/AIDS Spending at Summit
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. Diabetes and Depression often go hand-in-hand
10. Thirty minutes of work up per day reduces the risk of Diabetes
11. Diabetes on the rise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology: